First author

Abstract title

Presentation type and #

M. Gold

Ph III efficacy and safety data on relabotulinumtoxinA, an investigational liquid botulinum toxin for treatment of glabellar or lateral canthal lines

E-poster #134942

C. Persson

An Economic Model for a Recently Introduced Ready-to-Use Liquid Formulation of AbobotulinumtoxinA

E-poster #134943

M. Nestor

Evidence-based science behind the diffusion and spread of abobotulinumtoxinA

E-poster #134944

K. Beleznay

Safety and Effectiveness of Poly-L-lactic acid (PLLA-SCA) for the Improvement in Appearance of Cellulite – A Pilot Study

E-poster #134945

S. G. Fabi

A multi-center, retrospective, chart review to evaluate the safety of poly-L-lactic acid injectable implant when used in non-facial areas

E-poster #134946

A. Haddad

Utilizing the AART methodology to maximize aesthetic treatment outcomes across different patient profiles

E-poster #134947

A. Widgerow

A randomized, comparative study describing the gene signatures of Poly-L-Lactic Acid (PLLA-SCA) and Calcium Hydroxylapaptite (CaHA) in the treatment of nasolabial folds

E-poster #134948

L. Toledo Avelar

Physicochemical properties of two poly L-lactic acid dermal fillers: potential impact on their biological properties

E-poster #134949

A. Nikolis

Effectiveness and Safety of a New NASHA-HD Hyaluronic Acid Injectable, HA-SHA, for Augmentation and Correction of Chin Retrusion

E-poster #134950

A. Nikolis

A Snapshot in Time – Experts’ Main Concerns on Adverse Event Prevention and Management in Aesthetic Treatments with Hyaluronic Acid Fillers

E-poster #134951